Abstract
Tolerability and outcomes with rollout of tixagevimab-cilgavimab in patients with common variable immunodeficiency
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Paper Title
Journal
Date
More From: The journal of allergy and clinical immunology. Global
Paper Title
Journal
Date